lunedì, 2 dicembre 2024
Medinews
12 Ottobre 2018

Human medicine European public assessment report (EPAR): Pembrolizumab Merck Sharp Dohme

October 10, 2018 – This Human medicine European public assessment report (EPAR) was updated.
Leggi tutto

TORNA INDIETRO